Caspase signalling in neuropathic and inflammatory pain in the rat
- PMID: 15579143
- DOI: 10.1111/j.1460-9568.2004.03750.x
Caspase signalling in neuropathic and inflammatory pain in the rat
Abstract
Whereas small-fibre sensory neuropathies might ultimately lead to cell death and loss of sensation, they first progress through a phase, which might last for years, characterized by the presence of analgesia-resistant neuropathic dysesthesias and pain. Much previous research has addressed these two phases as separate phenomena mediated by presumably discrete biochemical mechanisms. We hypothesized that activity in signalling pathways that ultimately lead to apoptosis plays a critical role in the generation of neuropathic pain, before death of sensory neurons becomes apparent. We have tested the hypothesis that activator and effector caspases, defining components of programmed cell death (apoptosis) signalling pathways, also contribute to pain-related behaviour in animals with small-fibre peripheral neuropathies and that the death receptor ligand, tumour necrosis factor-alpha, and its downstream second messenger, ceramide, also produce pain-related behaviour via this mechanism. In two models of painful peripheral neuropathy, HIV/AIDS therapy (induced by the nucleoside reverse transcriptase inhibitor, dideoxycytidine), and cancer chemotherapy (induced by vincristine) peripheral neuropathy, and for pain-related behaviour induced by tumour necrosis factor-alpha and its second messenger, ceramide, inhibition of both activator (1, 2, 8 and 9) and effector (3) caspases attenuates neuropathic pain-related behaviour, although has no effect in streptozotocin-diabetic neuropathy and control rats. We conclude that during a latent phase, before apoptotic cell death is manifest, the caspase signalling pathway can contribute to pain in small-fibre peripheral neuropathies, and that inflammatory/immune mediators also activate these pathways. This suggests that these pathways are potential targets for novel pharmacological agents for the treatment of inflammatory as well as neuropathic pain.
Similar articles
-
Mitochondrial electron transport in models of neuropathic and inflammatory pain.Pain. 2006 Mar;121(1-2):105-14. doi: 10.1016/j.pain.2005.12.010. Epub 2006 Feb 10. Pain. 2006. PMID: 16472913
-
Role of Drp1, a key mitochondrial fission protein, in neuropathic pain.J Neurosci. 2011 Aug 3;31(31):11404-10. doi: 10.1523/JNEUROSCI.2223-11.2011. J Neurosci. 2011. PMID: 21813700 Free PMC article.
-
Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat.Pain. 2004 Jan;107(1-2):147-58. doi: 10.1016/j.pain.2003.10.010. Pain. 2004. PMID: 14715401
-
The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets.Drug Discov Today. 2006 Jan;11(1-2):8-20. doi: 10.1016/S1359-6446(05)03637-8. Drug Discov Today. 2006. PMID: 16478686 Review.
-
Exploring the molecular pathways and therapeutic implications of angiogenesis in neuropathic pain.Biomed Pharmacother. 2023 Jun;162:114693. doi: 10.1016/j.biopha.2023.114693. Epub 2023 Apr 14. Biomed Pharmacother. 2023. PMID: 37062217 Review.
Cited by
-
Caspase-1 modulates incisional sensitization and inflammation.Anesthesiology. 2010 Oct;113(4):945-56. doi: 10.1097/ALN.0b013e3181ee2f17. Anesthesiology. 2010. PMID: 20823759 Free PMC article.
-
Pterostilbene Ameliorates Fumonisin B1-Induced Cytotoxic Effect by Interfering in the Activation of JAK/STAT Pathway.Antioxidants (Basel). 2022 Nov 28;11(12):2360. doi: 10.3390/antiox11122360. Antioxidants (Basel). 2022. PMID: 36552567 Free PMC article.
-
Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms.Eur J Neurosci. 2010 Sep;32(5):811-8. doi: 10.1111/j.1460-9568.2010.07355.x. Epub 2010 Aug 19. Eur J Neurosci. 2010. PMID: 20726883 Free PMC article.
-
Changes of GTP cyclohydrolase I and neuronal apoptosis in rat spinal dorsal cord induced by sciatic nerve injury.Neurol Sci. 2013 Dec;34(12):2145-50. doi: 10.1007/s10072-013-1353-5. Epub 2013 Mar 21. Neurol Sci. 2013. PMID: 23515624
-
Targeting the Sphingosine-1-Phosphate Axis for Developing Non-narcotic Pain Therapeutics.Trends Pharmacol Sci. 2020 Nov;41(11):851-867. doi: 10.1016/j.tips.2020.09.006. Epub 2020 Oct 1. Trends Pharmacol Sci. 2020. PMID: 33010954 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical